论文部分内容阅读
瑞士免疫学家即将大量生产首次抗所有疟原虫的一种疫苗。Hoffman La Roche药品公司的Llri-ch Certa和日内瓦Canfonal医院的同事已完成大量生产疫苗所需要的合成蛋白的基因序列。瑞士的研究人员正用猴试验疫苗,预期在7月发表试验结果。当蚊子叮咬时,感染性有机体子孢子进入人体,即疟疾感染的开始。子孢子进入肝脏后,繁殖为千万个感染红细胞的裂殖子。
Swiss immunologists are about to mass-produce a vaccine that will fight all Plasmodium for the first time. Llri-ch Certa, a Hoffman La Roche drug company, and colleagues at the Canfonal Hospital in Geneva have completed the gene sequence for the synthetic protein required for mass production of the vaccine. Researchers in Switzerland are testing vaccines with monkeys and the test results are expected to be released in July. When mosquito bites, the infectious organism sporozoites enter the body, the beginning of malaria infection. Sporozoites into the liver, multiply millions of merozoites infected with red blood cells.